IMIPENEM AND CILASTATIN FOR INJECTION USP
SANDOZ CANADA INCORPORATED
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is IMIPENEM AND CILASTATIN FOR INJECTION USP discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG has been permanently discontinued (last updated August 23, 2021). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is IMIPENEM AND CILASTATIN FOR INJECTION USP not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02358336
Strength
250MG 250MG
Dosage Form
POWDER FOR SOLUTION
Route
INTRAVENOUS
Active Ingredient
CILASTATIN IMIPENEM
Compare with another product →
Shortage History
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495910
DIN 02495937
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759